Hyong Kim Sells 33,655 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 33,655 shares of the stock in a transaction that occurred on Wednesday, October 8th. The stock was sold at an average price of $17.29, for a total transaction of $581,894.95. Following the completion of the transaction, the insider owned 413,712 shares in the company, valued at approximately $7,153,080.48. This trade represents a 7.52% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Hyong Kim also recently made the following trade(s):

• On Thursday, October 9th, Hyong Kim sold 51,379 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.57, for a total transaction of $902,729.03.
• On Friday, August 22nd, Hyong Kim sold 24,800 shares of Alignment Healthcare stock. The stock was sold at an average price of $16.00, for a total transaction of $396,800.00.
• On Monday, August 11th, Hyong Kim sold 18,600 shares of Alignment Healthcare stock. The stock was sold at an average price of $14.54, for a total transaction of $270,444.00.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC opened at $17.31 on Friday. The stock has a market capitalization of $3.43 billion, a price-to-earnings ratio of -61.82 and a beta of 1.18. Alignment Healthcare, Inc. has a 12 month low of $10.11 and a 12 month high of $21.06. The firm’s 50 day simple moving average is $16.06 and its 200-day simple moving average is $15.66. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.14. The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The business’s revenue was up 49.0% on a year-over-year basis. During the same quarter last year, the company earned ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. MCF Advisors LLC lifted its holdings in Alignment Healthcare by 87.6% in the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after purchasing an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ purchased a new position in Alignment Healthcare in the 1st quarter valued at $42,000. SBI Securities Co. Ltd. raised its holdings in shares of Alignment Healthcare by 4,868.9% during the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after acquiring an additional 2,970 shares during the period. KBC Group NV purchased a new position in shares of Alignment Healthcare during the 2nd quarter worth $44,000. Finally, Amalgamated Bank raised its holdings in shares of Alignment Healthcare by 21.6% during the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock worth $65,000 after acquiring an additional 616 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on ALHC shares. KeyCorp raised shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price target on the stock in a research note on Monday, August 25th. Wall Street Zen cut shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday, August 10th. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 29th. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday. Finally, Barclays raised shares of Alignment Healthcare from an “underweight” rating to an “equal weight” rating and lifted their price target for the company from $9.00 to $13.00 in a research note on Thursday, July 31st. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $18.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.